Tabebuia impetiginosa herb
Tabebuia species are native to tropical rain forests throughout Central and South America and are used as a folk medicine to treat bacterial infection, cancer and inflammatory diseases. Tabelula impetiginosa is also known as Pau D'arco and sold as a dietary supplement.
Red Lapacho - A global ethnopharmacological commodity?
J Ethnopharmacol. 2009.
Centre for Pharmacognosy and Phytotherapy, The School of Pharmacy, University of
London, London, UK.
Red Lapacho, Tabebuia impetiginosa, is a canopy tree indigenous to the Amazonian
rainforest and other parts of South America. Tabebuia impetiginosa has been
acclaimed to be one of the "miraculous" cures for cancer and tumours. For the
first time, during the 1960s, it attracted considerable attention in Brazil and
Argentina as a 'wonder drug'. Traditionally, the botanical drug is widely used
in local and traditional phytomedicine, usually ingested as a decoction prepared
from the inner bark of the tree to treat numerous conditions like bacterial and
fungal infections, fever, syphilis, malaria, trypanosomiasis, as well as stomach
and bladder disorders. As early as 1873, biomedical uses of Red Lapacho ("Pau
D'Arco") were reported. In 1967 after reports in the Brazilian press it came
back to the light of clinicians (and the public in general). The news magazine
O'Cruzeiro started reporting "miraculous" cures in cancer patients in a
hospital. Natural sciences interest in the plant also began in the 1960s when
the United States National Cancer Institute (NCI) systematically began
researching plant extracts all over the world looking for active compounds
against cancer and looked at Tabebuia impetiginosa in considerable detail.
Active compounds
Two main bioactive components have been isolated from Tabebuia impetiginosa:
lapachol and beta-lapachone. beta-Lapachone is considered to be the main anti-tumour
compound, and pro-apoptotic effects were observed in vitro. Some mechanistic
studies on this compound's molecular effects have been conducted. The other main
constituents isolated from Red Lapacho are also reviewed briefly. The drug
appears to be generally safe and one of the most important interactions of
Tabebuia impetiginosa has been associated with interference in the biological
cycle of Vitamin K in the body. The botanical (drug) material available on the
international markets seems to be of varying quality and composition, making a
specific assessment of the products' therapeutic claims problematic. This also
highlights the need for appropriate analytical techniques, which are reviewed as
well.
Inhibitory effects of Tabebuia impetiginosa inner bark
extract on platelet aggregation and vascular smooth muscle cell proliferation
through suppressions of arachidonic acid liberation and ERK1/2 MAPK activation.
J Ethnopharmacol. 2006.
The antiplatelet and antiproliferative activities of extract of Tabebuia
impetiginosa inner bark were investigated using washed rabbit platelets and
cultured rat aortic vascular smooth muscle cells (VSMCs) in vitro. n-Hexane,
chloroform and ethyl acetate fractions showed marked and selective inhibition of
platelet aggregation induced by collagen and arachidonic acid (AA) in a
dose-dependent manner. These fractions, especially the chloroform fraction, also
significantly suppressed AA liberation induced by collagen in [(3)H]AA-labeled
rabbit platelets. The fractions, especially the chloroform fraction, potently
inhibited cell proliferation and DNA synthesis induced by platelet derived
growth factor (PDGF)-BB, and inhibited the levels of phosphorylated
extracellular signal regulated kinase (ERK1/2) mitogen activated protein kinase
(MAPK) stimulated by PDGF-BB, in the same concentration range that inhibits VSMC
proliferation and DNA synthesis.
tongkat ali herb